EMEA (Europe, Middle East and Africa) Imatinib Drugs Market Report 2017

COVID-19
Get in-depth analysis of the COVID-19 impact on this
Market/Industry



In this report, the EMEA Imatinib Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Imatinib Drugs for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Imatinib Drugs market competition by top manufacturers/players, with Imatinib Drugs sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including Apotex Inc. Novartis Sanofi S.A. Cipla Inc. Mylan Pharms Inc. Glenmark Pharmaceuticals Ltd. Sun Pharmaceuticals Actavis Generics Dr. Reddy's Laboratories Teva Pharmaceutical Industries Ltd. On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into Capsules Tablets On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Hospitals Drug Stores Other If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

EMEA (Europe, Middle East and Africa) Imatinib Drugs Market Report 2017
1 Imatinib Drugs Overview
    1.1 Product Overview and Scope of Imatinib Drugs
    1.2 Classification of Imatinib Drugs
        1.2.1 EMEA Imatinib Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Imatinib Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Capsules
        1.2.4 Tablets
    1.3 EMEA Imatinib Drugs Market by Application/End Users
        1.3.1 EMEA Imatinib Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Drug Stores
        1.3.4 Other
    1.4 EMEA Imatinib Drugs Market by Region
        1.4.1 EMEA Imatinib Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Imatinib Drugs (2012-2022)
        1.5.1 EMEA Imatinib Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Imatinib Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Imatinib Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Imatinib Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Imatinib Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Imatinib Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Imatinib Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Imatinib Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Imatinib Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Imatinib Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Imatinib Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Imatinib Drugs (Volume) by Application
    2.4 EMEA Imatinib Drugs (Volume and Value) by Region
        2.4.1 EMEA Imatinib Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Imatinib Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Imatinib Drugs Sales Price by Region (2012-2017)

3 Europe Imatinib Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Imatinib Drugs Sales and Value (2012-2017)
        3.1.1 Europe Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Imatinib Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Imatinib Drugs Sales and Market Share by Type
    3.3 Europe Imatinib Drugs Sales and Market Share by Application
    3.4 Europe Imatinib Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Imatinib Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Imatinib Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Imatinib Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Imatinib Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Imatinib Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Imatinib Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Imatinib Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Imatinib Drugs Sales and Growth Rate (2012-2017)

4 Middle East Imatinib Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Imatinib Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Imatinib Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Imatinib Drugs Sales and Market Share by Type
    4.3 Middle East Imatinib Drugs Sales and Market Share by Application
    4.4 Middle East Imatinib Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Imatinib Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Imatinib Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Imatinib Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Imatinib Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Imatinib Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Imatinib Drugs Sales and Growth Rate (2012-2017)

5 Africa Imatinib Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Imatinib Drugs Sales and Value (2012-2017)
        5.1.1 Africa Imatinib Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Imatinib Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Imatinib Drugs Sales and Market Share by Type
    5.3 Africa Imatinib Drugs Sales and Market Share by Application
    5.4 Africa Imatinib Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Imatinib Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Imatinib Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Imatinib Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Imatinib Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Imatinib Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Imatinib Drugs Sales and Growth Rate (2012-2017)

6 EMEA Imatinib Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Apotex Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Imatinib Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Imatinib Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Sanofi S.A.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Imatinib Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cipla Inc.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Imatinib Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Mylan Pharms Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Imatinib Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Glenmark Pharmaceuticals Ltd.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Imatinib Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sun Pharmaceuticals
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Imatinib Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Actavis Generics
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Imatinib Drugs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Actavis Generics Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Dr. Reddy's Laboratories
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Imatinib Drugs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Teva Pharmaceutical Industries Ltd.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Imatinib Drugs Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Imatinib Drugs Manufacturing Cost Analysis
    7.1 Imatinib Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Imatinib Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Imatinib Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Imatinib Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Imatinib Drugs Market Forecast (2017-2022)
    11.1 EMEA Imatinib Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Imatinib Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Imatinib Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Imatinib Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Imatinib Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Imatinib Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Imatinib Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Imatinib Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Imatinib Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Imatinib Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer



List of Tables and Figures

    Figure Product Picture of Imatinib Drugs
    Figure EMEA Imatinib Drugs Sales Volume (MT) by Type (2012-2022)
    Figure EMEA Imatinib Drugs Sales Volume Market Share by Type (Product Category) in 2016
    Figure Capsules Product Picture
    Figure Tablets Product Picture
    Figure EMEA Imatinib Drugs Sales Volume (MT) by Application (2012-2022)
    Figure EMEA Sales Market Share of Imatinib Drugs by Application in 2016
    Figure Hospitals Examples
    Table Key Downstream Customer in Hospitals
    Figure Drug Stores Examples
    Table Key Downstream Customer in Drug Stores
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure EMEA Imatinib Drugs Market Size (Million USD) by Region (2012-2022)
    Figure Europe Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Imatinib Drugs Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Middle East Imatinib Drugs Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Africa Imatinib Drugs Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Imatinib Drugs Sales Volume and Growth Rate (2012-2022)
    Figure EMEA Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure EMEA Imatinib Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
    Table EMEA Imatinib Drugs Sales Volume (MT) of Major Players (2012-2017)
    Table EMEA Imatinib Drugs Sales Share by Players (2012-2017)
    Figure 2016 Imatinib Drugs Sales Share by Players
    Figure 2017 Imatinib Drugs Sales Share by Players
    Figure EMEA Imatinib Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
    Table EMEA Imatinib Drugs Revenue (Million USD) by Players (2012-2017)
    Table EMEA Imatinib Drugs Revenue Share by Players (2012-2017)
    Table 2016 EMEA Imatinib Drugs Revenue Share by Players
    Table 2017 EMEA Imatinib Drugs Revenue Share by Players
    Table EMEA Imatinib Drugs Sale Price (USD/Kg) by Players (2012-2017)
    Table EMEA Imatinib Drugs Sales (MT) and Market Share by Type (2012-2017)
    Table EMEA Imatinib Drugs Sales Share by Type (2012-2017)
    Figure Sales Market Share of Imatinib Drugs by Type (2012-2017)
    Figure EMEA Imatinib Drugs Sales Market Share by Type (2012-2017)
    Table EMEA Imatinib Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    Table EMEA Imatinib Drugs Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Imatinib Drugs by Type in 2016
    Table EMEA Imatinib Drugs Sale Price (USD/Kg) by Type (2012-2017)
    Table EMEA Imatinib Drugs Sales (MT) and Market Share by Application (2012-2017)
    Table EMEA Imatinib Drugs Sales Share by Application (2012-2017)
    Figure Sales Market Share of Imatinib Drugs by Application (2012-2017)
    Figure EMEA Imatinib Drugs Sales Market Share by Application in 2016
    Table EMEA Imatinib Drugs Sales (MT) and Market Share by Region (2012-2017)
    Table EMEA Imatinib Drugs Sales Share by Region (2012-2017)
    Figure Sales Market Share of Imatinib Drugs by Region (2012-2017)
    Figure EMEA Imatinib Drugs Sales Market Share in 2016
    Table EMEA Imatinib Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    Table EMEA Imatinib Drugs Revenue Share by Region (2012-2017)
    Figure Revenue Market Share of Imatinib Drugs by Region (2012-2017)
    Figure EMEA Imatinib Drugs Revenue Market Share Regions in 2016
    Table EMEA Imatinib Drugs Sales Price (USD/Kg) by Region (2012-2017)
    Figure Europe Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Europe Imatinib Drugs Revenue and Growth Rate (2012-2017)
    Table Europe Imatinib Drugs Sales (MT) by Type (2012-2017)
    Table Europe Imatinib Drugs Market Share by Type (2012-2017)
    Figure Europe Imatinib Drugs Market Share by Type in 2016
    Table Europe Imatinib Drugs Sales (MT) by Application (2012-2017)
    Table Europe Imatinib Drugs Market Share by Application (2012-2017)
    Figure Europe Imatinib Drugs Market Share by Application in 2016
    Table Europe Imatinib Drugs Sales (MT) by Countries (2012-2017)
    Table Europe Imatinib Drugs Sales Market Share by Countries (2012-2017)
    Figure Europe Imatinib Drugs Sales Market Share by Countries (2012-2017)
    Figure Europe Imatinib Drugs Sales Market Share by Countries in 2016
    Table Europe Imatinib Drugs Revenue (Million USD) by Countries (2012-2017)
    Table Europe Imatinib Drugs Revenue Market Share by Countries (2012-2017)
    Figure Europe Imatinib Drugs Revenue Market Share by Countries (2012-2017)
    Figure Europe Imatinib Drugs Revenue Market Share by Countries in 2016
    Figure Germany Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure France Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure UK Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Russia Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Italy Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Benelux Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Middle East Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Middle East Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Table Middle East Imatinib Drugs Sales (MT) by Type (2012-2017)
    Table Middle East Imatinib Drugs Market Share by Type (2012-2017)
    Figure Middle East Imatinib Drugs Market Share by Type (2012-2017)
    Table Middle East Imatinib Drugs Sales (MT) by Applications (2012-2017)
    Table Middle East Imatinib Drugs Market Share by Applications (2012-2017)
    Figure Middle East Imatinib Drugs Sales Market Share by Application in 2016
    Table Middle East Imatinib Drugs Sales Volume (MT) by Countries (2012-2017)
    Table Middle East Imatinib Drugs Sales Volume Market Share by Countries (2012-2017)
    Figure Middle East Imatinib Drugs Sales Volume Market Share by Countries in 2016
    Table Middle East Imatinib Drugs Revenue (Million USD) by Countries (2012-2017)
    Table Middle East Imatinib Drugs Revenue Market Share by Countries (2012-2017)
    Figure Middle East Imatinib Drugs Revenue Market Share by Countries (2012-2017)
    Figure Middle East Imatinib Drugs Revenue Market Share by Countries in 2016
    Figure Saudi Arabia Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Israel Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure UAE Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Iran Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Africa Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Africa Imatinib Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Table Africa Imatinib Drugs Sales (MT) by Type (2012-2017)
    Table Africa Imatinib Drugs Sales Market Share by Type (2012-2017)
    Figure Africa Imatinib Drugs Sales Market Share by Type (2012-2017)
    Figure Africa Imatinib Drugs Sales Market Share by Type in 2016
    Table Africa Imatinib Drugs Sales (MT) by Application (2012-2017)
    Table Africa Imatinib Drugs Sales Market Share by Application (2012-2017)
    Figure Africa Imatinib Drugs Sales Market Share by Application (2012-2017)
    Table Africa Imatinib Drugs Sales Volume (MT) by Countries (2012-2017)
    Table Africa Imatinib Drugs Sales Market Share by Countries (2012-2017)
    Figure Africa Imatinib Drugs Sales Market Share by Countries (2012-2017)
    Figure Africa Imatinib Drugs Sales Market Share by Countries in 2016
    Table Africa Imatinib Drugs Revenue (Million USD) by Countries (2012-2017)
    Table Africa Imatinib Drugs Revenue Market Share by Countries (2012-2017)
    Figure Africa Imatinib Drugs Revenue Market Share by Countries (2012-2017)
    Figure Africa Imatinib Drugs Revenue Market Share by Countries in 2016
    Figure South Africa Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Nigeria Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Egypt Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Algeria Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Table Apotex Inc. Imatinib Drugs Basic Information List
    Table Apotex Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Apotex Inc. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Apotex Inc. Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Apotex Inc. Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Novartis Imatinib Drugs Basic Information List
    Table Novartis Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Novartis Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Novartis Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Novartis Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Sanofi S.A. Imatinib Drugs Basic Information List
    Table Sanofi S.A. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Sanofi S.A. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Sanofi S.A. Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Sanofi S.A. Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Cipla Inc. Imatinib Drugs Basic Information List
    Table Cipla Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Cipla Inc. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Cipla Inc. Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Cipla Inc. Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Mylan Pharms Inc. Imatinib Drugs Basic Information List
    Table Mylan Pharms Inc. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Mylan Pharms Inc. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Mylan Pharms Inc. Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Mylan Pharms Inc. Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Basic Information List
    Table Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Glenmark Pharmaceuticals Ltd. Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Sun Pharmaceuticals Imatinib Drugs Basic Information List
    Table Sun Pharmaceuticals Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Sun Pharmaceuticals Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Sun Pharmaceuticals Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Sun Pharmaceuticals Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Actavis Generics Imatinib Drugs Basic Information List
    Table Actavis Generics Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Actavis Generics Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Actavis Generics Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Actavis Generics Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Dr. Reddy's Laboratories Imatinib Drugs Basic Information List
    Table Dr. Reddy's Laboratories Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Dr. Reddy's Laboratories Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Dr. Reddy's Laboratories Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Dr. Reddy's Laboratories Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Basic Information List
    Table Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (MT) and Growth Rate (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Market Share in EMEA (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Imatinib Drugs Revenue Market Share in EMEA (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Imatinib Drugs
    Figure Manufacturing Process Analysis of Imatinib Drugs
    Figure Imatinib Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Imatinib Drugs Major Manufacturers in 2016
    Table Major Buyers of Imatinib Drugs
    Table Distributors/Traders List
    Figure EMEA Imatinib Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
    Figure EMEA Imatinib Drugs Revenue and Growth Rate Forecast (2017-2022)
    Figure EMEA Imatinib Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
    Table EMEA Imatinib Drugs Sales (MT) Forecast by Region (2017-2022)
    Figure EMEA Imatinib Drugs Sales Market Share Forecast by Region (2017-2022)
    Table EMEA Imatinib Drugs Revenue (Million USD) Forecast by Region (2017-2022)
    Figure EMEA Imatinib Drugs Revenue Market Share Forecast by Region (2017-2022)
    Table Europe Imatinib Drugs Sales (MT) Forecast by Countries (2017-2022)
    Figure Europe Imatinib Drugs Sales Market Share Forecast by Countries (2017-2022)
    Table Europe Imatinib Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Europe Imatinib Drugs Revenue Market Share Forecast by Countries (2017-2022)
    Table Middle East Imatinib Drugs Sales (MT) Forecast by Countries (2017-2022)
    Figure Middle East Imatinib Drugs Sales Market Share Forecast by Countries (2017-2022)
    Table Middle East Imatinib Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Middle East Imatinib Drugs Revenue Market Share Forecast by Countries (2017-2022)
    Table Africa Imatinib Drugs Sales (MT) Forecast by Countries (2017-2022)
    Figure Africa Imatinib Drugs Sales Market Share Forecast by Countries (2017-2022)
    Table Africa Imatinib Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Africa Imatinib Drugs Revenue Market Share Forecast by Countries (2017-2022)
    Table EMEA Imatinib Drugs Sales (MT) Forecast by Type (2017-2022)
    Figure EMEA Imatinib Drugs Sales Market Share Forecast by Type (2017-2022)
    Table EMEA Imatinib Drugs Sales (MT) Forecast by Application (2017-2022)
    Figure EMEA Imatinib Drugs Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Enquiry Before
   Purchase
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf